Prolight Diagnostics
0.388
SEK
-1.77 %
Less than 1K followers
PRLD
Nordic SME
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
-1.77%
-21.3%
+72.44%
+189.55%
+171.33%
+160.4%
+21.63%
-83.49%
-9.77%
Prolight Diagnostics develops test systems in POCT (Point of care testing). The tests are used outside of hospital laboratories to enable rapid assessments of the health of patients. The company's POCT platform is under development with the intention of measuring various biomarkers simultaneously. An important component of the work is to reduce the time for test results, particularly important for patients with heart problems. The company was founded in 1999 and is based in Lund.
Read moreMarket cap
272.41M SEK
Turnover
499.98K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
30/5
2025
Interim report Q1'25
24/6
2025
General meeting '25
28/8
2025
Interim report Q2'25
All
Webcasts
Press releases
3rd party
ShowingAll content types
Prolight receives new MicroFlex patent approval in the US
Prolight erhåller sina två första europeiska patent för Psyros™-teknologin
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools